These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7298873)

  • 1. Antiepileptic potential of cannabidiol analogs.
    Consroe P; Martin A; Singh V
    J Clin Pharmacol; 1981; 21(S1):428S-436S. PubMed ID: 7298873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-anticonvulsant activity relationships of cannabidiol analogs.
    Martin AR; Consroe P; Kane VV; Shah V; Singh V; Lander N; Mechoulam R; Srebnik M
    NIDA Res Monogr; 1987; 79():48-58. PubMed ID: 3125480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
    Consroe P; Wolkin A
    J Pharmacol Exp Ther; 1977 Apr; 201(1):26-32. PubMed ID: 850145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.
    Yamaori S; Okamoto Y; Yamamoto I; Watanabe K
    Drug Metab Dispos; 2011 Nov; 39(11):2049-56. PubMed ID: 21821735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats.
    Turkanis SA; Smiley KA; Borys HK; Olsen DM; Karler R
    Epilepsia; 1979 Aug; 20(4):351-63. PubMed ID: 477630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
    Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
    Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
    Klein BD; Jacobson CA; Metcalf CS; Smith MD; Wilcox KS; Hampson AJ; Kehne JH
    Neurochem Res; 2017 Jul; 42(7):1939-1948. PubMed ID: 28478594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.
    Yamaori S; Ebisawa J; Okushima Y; Yamamoto I; Watanabe K
    Life Sci; 2011 Apr; 88(15-16):730-6. PubMed ID: 21356216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant activity of four oxygenated cannabidiol derivatives.
    Carlini EA; Mechoulam R; Lander N
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):1-15. PubMed ID: 1188178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anticonvulsant effects of cannabidiol in experimental models of epileptic seizures: From behavior and mechanisms to clinical insights.
    Lazarini-Lopes W; Do Val-da Silva RA; da Silva-Júnior RMP; Leite JP; Garcia-Cairasco N
    Neurosci Biobehav Rev; 2020 Apr; 111():166-182. PubMed ID: 31954723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
    Jones NA; Hill AJ; Smith I; Bevan SA; Williams CM; Whalley BJ; Stephens GJ
    J Pharmacol Exp Ther; 2010 Feb; 332(2):569-77. PubMed ID: 19906779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cannabinoids as potential antiepileptics.
    Karler R; Turkanis SA
    J Clin Pharmacol; 1981; 21(S1):437S-448S. PubMed ID: 6975285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol.
    Yamaori S; Okushima Y; Yamamoto I; Watanabe K
    Chem Biol Interact; 2014 May; 215():62-8. PubMed ID: 24667653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety.
    Yamaori S; Okushima Y; Masuda K; Kushihara M; Katsu T; Narimatsu S; Yamamoto I; Watanabe K
    Biol Pharm Bull; 2013; 36(7):1197-203. PubMed ID: 23811569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
    Jones NA; Glyn SE; Akiyama S; Hill TD; Hill AJ; Weston SE; Burnett MD; Yamasaki Y; Stephens GJ; Whalley BJ; Williams CM
    Seizure; 2012 Jun; 21(5):344-52. PubMed ID: 22520455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cannabidiol-mediated cytochrome P450 inactivation.
    Bornheim LM; Everhart ET; Li J; Correia MA
    Biochem Pharmacol; 1993 Mar; 45(6):1323-31. PubMed ID: 8466552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cannabidiol (CBD) administration induces anticonvulsant and antiepileptogenic effects in a genetic model of epilepsy.
    Lazarini-Lopes W; Do Val-da Silva RA; da Silva-Júnior RMP; Silva-Cardoso GK; Leite-Panissi CRA; Leite JP; Garcia-Cairasco N
    Epilepsy Behav; 2021 Jun; 119():107962. PubMed ID: 33887676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsive Effects and Pharmacokinetic Profile of Cannabidiol (CBD) in the Pentylenetetrazol (PTZ) or N-Methyl-D-Aspartate (NMDA) Models of Seizures in Infantile Rats.
    Uttl L; Hložek T; Mareš P; Páleníček T; Kubová H
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats.
    Chiu P; Olsen DM; Borys HK; Karler R; Turkanis SA
    Epilepsia; 1979 Aug; 20(4):365-75. PubMed ID: 113206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials.
    Turkanis SA; Chiu P; Borys HK; Karler R
    Psychopharmacology (Berl); 1977 Apr; 52(2):207-12. PubMed ID: 407606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.